Renin

Hypertension

Volumn , Issue , 2005, Pages 89-94

  Reudelhuber, Timothy L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34948861557     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50098-3     Document Type: Chapter

References (46)

1. Hall JE Historical perspective of the renin-angiotensin system. Mol Biotechnol 2003, 24:27-39.
2. Lum C, Shesely EG, Potter DL, et al. Cardiovascular and renal phenotype in mice with one or two renin genes. Hypertension 2004, 43:79-86.
3. Wang PH, Do YS, Macaulay L, et al. Identification of renal cathepsin B as a human prorenin-processing enzyme. J Biol Chem 1991, 266:12633-12638.
4. Mercure C, Jutras I, Day R, et al. Prohormone convertase PC5 is a candidate processing enzyme for prorenin in the human adrenal cortex. Hypertension 1996, 28:840-846.
5. Reudelhuber TL, Ramla D, Chiu L, et al. Proteolytic processing of human prorenin in renal and non-renal tissues. Kidney Int 1994, 46:1522-1524.
6. Taugner R, Kim SJ, Murakami K, et al. The fate of prorenin during granulopoiesis in epithelioid cells. Immunocytochemical experiments with antisera against renin and different portions of the renin prosegment. Histochemistry 1987, 86:249-253.
7. Pratt RE, Carleton JE, Richie JP, et al. Human renin biosynthesis and secretion in normal and ischemic kidneys. Proc Natl Acad Sci USA 1987, 84:7837-7840.
8. Plouin PF, Chatellier G, Guyene TT, et al. Recent advances in the clinical study of the renin system. Reference values and conditions of validity. Presse Med 1989, 18:917-921.
9. Hsueh WA, Baxter JD Human prorenin. Hypertension 1991, 17:469-477.
10. Re RN Intracellular renin and the nature of intracrine enzymes. Hypertension 2003, 42:117-122.
11. Sealey JE, Catanzaro DF, Lavin TN, et al. Specific prorenin/ renin binding (ProBP). Identification and characterization of a novel membrane site. Am J Hypertens 1996, 9:491-502.
12. van den Eijnden MM, Saris JJ, de Bruin RJ, et al. Prorenin accumulation and activation in human endothelial cells: Importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 2001, 21:911-916.
13. Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
14. Lavoie JL, Sigmund CD Minireview: Overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003, 144:2179-2183.
15. Sealey JE, White RP, Laragh JH, et al. Plasma prorenin and renin in anephric patients. Circ Res 1977, 41:17-21.
16. Prescott G, Silversides DW, Reudelhuber TL Tissue activity of circulating prorenin. Am J Hypertens 2002, 15:280-285.
17. Prescott G, Silversides DW, Chiu SM, et al. Contribution of circulating renin to local synthesis of angiotensin peptides in the heart. Physiol Genomics 2000, 4:67-73.
18. Methot D, Silversides DW, Reudelhuber TL In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res 1999, 84:1067-1072.
19. Admiraal PJ, van Kesteren CA, Danser AH, et al. Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J Hypertens 1999, 17:621-629.
20. Plouin PF, Cudek P, Arnal JF, et al. Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis. Horm Res 1990, 34:138-141.
21. Gould AB, Green D Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971, 5:86-89.
22. Alderman MH, Madhavan S, Ooi WL, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991, 324:1098-1104.
23. Meade TW, Cooper JA, Peart WS Plasma renin activity and ischemic heart disease. N Engl J Med 1993, 329:616-619.
24. Alderman MH, Sealey JE, Laragh JH Plasma renin activity and ischemic heart disease. N Engl J Med 1994, 330:506-507.
25. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992, 71:169-180.
26. Zhu X, Chang YP, Yan D, et al. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003, 41:1027-1034.
27. Jeunemaitre X, Rigat B, Charru A, et al. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992, 88:301-306.
28. Lifton RP, Wilson FH, Choate KA, et al. Salt and blood pressure: New insight from human genetic studies. Cold Spring Harb Symp Quant Biol 2002, 67:445-450.
29. Thiel BA, Chakravarti A, Cooper RS, et al. A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens 2003, 16:151-153.
30. Pryde PG, Sedman AB, Nugent CE, et al. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993, 3:1575-1582.
31. Yanai K, Saito T, Kakinuma Y, et al. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000, 275:5-8.
32. Gurley SB, Le TH, Coffman TM Gene-targeting studies of the renin-angiotensin system: Mechanisms of hypertension and cardiovascular disease. Cold Spring Harb Symp Quant Biol 2002, 67:451-457.
33. Nishimura H, Yerkes E, Hohenfellner K, et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999, 3:1-10.
34. Meade TW, Imeson JD, Gordon D, et al. The epidemiology of plasma renin. Clin Sci (Lond) 1983, 64:273-280.
35. Alderman MH, Cohen HW, Sealey JE, et al. Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 2004, 17:1-7.
36. Laragh JH Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension. Am J Hypertens 2001, 14:1173-1177.
37. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimental hypertension: Production of persistent elevation of systolic pressure by means of renal ischemia. J Exp Med 1934, 59:347-380.
38. Samani NJ, Godfrey NP, Major JS, et al. Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat. J Hypertens 1989, 7:105-112.
39. Safian RD Atherosclerotic renal artery stenosis. Curr Treat Options Cardiovasc Med 2003, 5:91-101.
40. Bruni KR Renovascular hypertension. J Cardiovasc Nurs 2001, 15:78-90.
41. Corvol P, Pinet F, Plouin PF, et al. Renin-secreting tumors. Endocrinol Metab Clin North Am 1994, 23:255-270.
42. Martin SA, Mynderse LA, Lager DJ, et al. Juxtaglomerular cell tumor: A clinicopathologic study of four cases and review of the literature. Am J Clin Pathol 2001, 116:854-863.
43. Koriyama N, Kakei M, Yaekura K, et al. A case of renal juxtaglomerular cell tumor: Usefulness of segmental sampling to prove autonomic secretion of the tumor. Am J Med Sci 1999, 318:194-197.
44. Kashiwabara H, Inaba M, Itabashi A, et al. A case of renin-pro-ducing juxtaglomerular tumor: Effect of ACE inhibitor or angiotensin II receptor antagonist. Blood Press 1997, 6:147-153.
45. Arver S, Jacobsson H, Cedermark B, et al. Malignant human renin producing paraganglionoma-localization with 123I-MIBG and treatment with 131I-MIBG. Clin Endocrinol (Oxf) 1999, 51:631-635.
46. Fisher ND, Hollenberg NK Is there a future for renin inhibitors?. Expert Opin Investig Drugs 2001, 10:417-426.